Related Experiment Video
Updated: Aug 9, 2026

Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model
Published on: October 16, 2017
Oncolysis of pancreatic tumour cells by a gamma34.5-deleted HSV-1 does not rely upon Ras-activation, but on the PI
F Sarinella1, A Calistri, P Sette
1Department of Histology, Microbiology and Medical Biotechnologies, Section of Microbiology and Virology, Medical School, University of Padua, Padua, Italy.
Abstract:
The ability of viruses to selectively target, replicate within, and destroy tumour cells without deleterious effects in normal cells (oncolysis), makes the use of viruses as an attractive tool for cancer treatment. Pancreatic adenocarcinoma, being insensitive to traditional therapy and having a rather poor prognosis, represents a suitable target to evaluate viral oncolysis as a novel therapeutic approach. Herpes simplex virus (HSV) has been reported to produce an oncolytic effect in cells overexpressing Ras. As Ras signalling is frequently aberrant in pancreatic cancer, we compared four pancreatic cell lines (which differ in the presence of mutated or wild-type ras) for their ability to support growth of gamma34.5-replication attenuated HSV-1 (R3616). Our data show that permissiveness to viral replication is neither associated with enhanced Ras signalling nor with defective PKR activity. By contrast, we provide evidence that disregulation of the PI 3-kinase signalling pathway allows conditionally replication-defective R3616 virus to overcome the cellular antiviral activity.
Insights
Oncolytic viruses offer a promising cancer therapy. This study found that PI 3-kinase pathway dysregulation, not Ras signaling, enables replication-defective herpes simplex virus (HSV) to overcome antiviral defenses in pancreatic cancer cells.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Oncolysis, using viruses to destroy tumor cells, is a promising cancer therapy.
- Pancreatic adenocarcinoma is aggressive and poorly responsive to conventional treatments.
- Herpes simplex virus (HSV) shows oncolytic potential, particularly in Ras-overexpressing cells, common in pancreatic cancer.
Purpose of the Study:
- To evaluate the potential of oncolytic viruses for pancreatic cancer treatment.
- To investigate the role of Ras signaling and PKR activity in supporting herpes simplex virus replication in pancreatic cancer cells.
- To identify cellular factors that permit replication of attenuated HSV-1 (R3616) in pancreatic cancer.
Main Methods:
- Comparison of viral replication in four pancreatic cell lines with varying Ras signaling.
- Assessment of viral permissiveness in relation to Ras pathway activation and PKR activity.
- Investigation of the PI 3-kinase signaling pathway's role in viral replication.
Main Results:
- Viral replication permissiveness in pancreatic cancer cells did not correlate with enhanced Ras signaling or defective PKR activity.
- The PI 3-kinase signaling pathway was identified as a key factor enabling viral replication.
- Dysregulation of the PI 3-kinase pathway allows the conditionally replication-defective R3616 HSV-1 strain to overcome cellular antiviral responses.
Conclusions:
- Ras signaling and PKR activity are not the primary determinants of HSV replication in pancreatic cancer.
- PI 3-kinase pathway dysregulation is crucial for overcoming cellular antiviral defenses and enabling oncolytic HSV replication in pancreatic cancer.
- Targeting the PI 3-kinase pathway may enhance the efficacy of oncolytic herpes simplex virus therapy for pancreatic adenocarcinoma.
More Related Videos
Related Concept Videos
The Ras Gene
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

